Given the size of the market, however, that doesnt seem feasible at this point in the U.S
FDA-approved Mounjaro (tirzepatide) is a GLP-1 medication used for treating diabetes in adults who have a body mass index (BMI) over 27, have hypertension or dyslipidemia, or are obese ( BMI over 30)
Starting with lower doses, keeping detailed notes on effects, and being prepared to discontinue if unexpected responses occur represents a prudent approach
In general, its best if you consume 20-25 grams (0.70-0.09 ounces) of protein post-workout, too
Disparities in the glycemic and incretin responses to intraduodenal glucose infusion between healthy young men and women
doi:10.1007/s12349-010-0045-4 Alijaniha F, Naseri M, Afsharypuor S, et al